Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Grifols announces takeover of Talecris Biotherapeutics

Grifols announces takeover of Talecris Biotherapeutics

7th June 2010

Grifols has announced an agreement to acquire Talecris Biotherapeutics in a deal valued at around $3.4 billion (2.3 billion pounds).

The takeover will see Grifols expand its presence in the international plasma protein therapies market, providing a greater global footprint and increased manufacturing capabilities, as well as unifying complementary products in a single portfolio.

It states that this will allow the combined company to conduct research into a wide range of fields, addressing a variety of patient needs, as well as providing improved cost efficiency and profitability.

Victor Grifols, chairman and chief executive officer of Grifols, said: “The acquisition of Talecris furthers our vision to better serve patients and healthcare professionals with innovative products, a strong clinical research capability and new research into recombinant therapies.”

According to Grifols’ most recent financial report in April, the company experienced a strong first quarter in 2010, with total income for the three months increasing by 3.1 per cent year-on-year.

We currently have 6 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.